Skip to content

Evaluation of the VEGA Knee System® Range of Motion

Prospective, Long-Term, Multi-Center Study on the Efficacy of the VEGA System® for Total Knee Arthroplasty.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01768871
Enrollment
7
Registered
2013-01-16
Start date
2013-01-31
Completion date
2015-07-31
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Total Knee Arthroplasty Using the VEGA System

Brief summary

The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.

Detailed description

To evaluate patients after total knee arthroplasty in terms of function for five years.

Interventions

None listed

Sponsors

Aesculap Implant Systems
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* willing to sign the informed consent. * Patient has intact collateral ligaments.

Exclusion criteria

* Inflammatory arthritis * Patients that have had a high tibial osteotomy or femoral osteotomy * Patients with neuromuscular or neurosensory deficiency which would make it difficult to assess the device performance.

Design outcomes

Primary

MeasureTime frameDescription
WOMACTwo yearsWOMAC function score 2 years post arthroplasty

Secondary

MeasureTime frame
Health related quality of lifeTwo years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026